Research News and Research

RSS

Daschle advising Obama, health industry on reform

The Washington Post: "Former Senate majority leader Thomas A. Daschle's visit to the Oval Office on Friday, at the invitation of President Obama, was more than just a meeting between two loyal friends and political allies. It also served as a reminder of what might have been."

23 Aug 2009

Brits defend National Health Service against U.S. criticism

The United Kingdom's National Health System enters into the health care debate amid comparisons of the British and American health care systems. Meanwhile, British politicians defend NHS against critics.

23 Aug 2009

Dems in conflict on health reform options, Mccain defends GOP 'end of life' claims

The Associated Press: "Some lawmakers have suggested that a separate bill with changes that are supported by Republicans and Democrats would be one route toward progress on the health care overhaul. But a member of the Senate Finance Committee, Democratic Sen. Kent Conrad of North Dakota, says he doesn't see how lawmakers could get two health care bills through Congress and coordinate them well." Conrad spoke on CBS' "Face The Nation" (8/23).

23 Aug 2009

House Liberals: Bill must include public option

"With the battle over health care reform heating up over the issue of a public insurance option, Speaker Nancy Pelosi said Thursday that the House must pass an overhaul that includes a public option," the San Francisco Chronicle reports. The comments came at a San Francisco news conference.

23 Aug 2009

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).

22 Aug 2009

MarrowXpress System used for isolation and retrieval of bone marrow-derived adult stem cells

Celling Technologies collaborated with innovative cell processing expert, ThermoGenesis Corp., to deliver the most sophisticated point of care cell separation device on the market. The innovative MarrowXpress(TM) (MXP(TM)) System defines a new standard for isolation and retrieval of bone marrow-derived adult stem cells.

21 Aug 2009

Cortex Pharmaceuticals receives delisting notification from NYSE Amex

Cortex Pharmaceuticals, Inc. (NYSE Amex (COR)) reported that it has received a delisting notification from the NYSE Amex LLC indicating that it has not accepted the Company’s plan to regain compliance with the Exchange’s continued listing standards, as submitted by the Company in June.

21 Aug 2009

Vendor-neutral sales performance management community launched by SPM leader Callidus Software

Callidus Software Inc. (NASDAQ: CALD), the leader in Sales Performance Management (SPM), today launched OpenCommissions, the industry's only vendor-neutral sales performance management community. OpenCommissions includes discussion groups on best practices, sales and compensation that allow members to exchange experiences, share opinions and give advice.

21 Aug 2009

PTSD could be treated with Craniosacral therapy according to a research study

Post-traumatic stress disorder (PTSD) is impacting people worldwide. In the United States alone, more than five million people will suffer from PTSD this year. There are major emotional, financial, and negative health implications associated with PTSD making it a timely priority.

21 Aug 2009

Ron Demuth of ChemDiv announces extension of collaboration with Lilly

ChemDiv, Inc. announced the expansion of its drug discovery collaboration with Eli Lilly through 2010. Under the terms of the agreement, the partners will identify and develop leads for an additional therapeutic target using ChemDiv's small molecule resources (the industry's largest commercial collection) and Discovery outSource™ drug discovery and development platforms.

21 Aug 2009

Condom Olympics event to select an ambassador from Miss Universe contestants to spread messages about HIV prevention

The Miss Universe contestants continued preparations for Sunday night's pageant by competing today in the Condom Olympics - tossing water-filled condoms to test their strength and playing "Wild Fire Infection" games that demonstrate the serious side of HIV infection.

21 Aug 2009

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

...

21 Aug 2009

HCCA's Research Compliance Conference to address Compliance Issues in International Clinical Trials

...

21 Aug 2009

State round-up: Colorado's medicaid woes, Utah's Health Exchange, and more

Thursday's state news includes concerns over Medicaid reimbursement cuts in Colorado, the opening of the Utah Health Exchange amidst skyrocketing premiums and the high number of uninsured in Texas.

21 Aug 2009

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

HeartWare International, Inc. (Nasdaq: HTWR - ASX: HIN) today announced that HeartWare has surpassed 50 implants in the United States under its ADVANCE Clinical Trial, marking an important early enrollment milestone.

21 Aug 2009

Inc. magazine ranks Signature Genomic Laboratories no.1012 on its fastest-growing private companies ranking list

Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.

21 Aug 2009

Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials

Stemedica Cell Technologies, Inc. USA, a leader in adult stem cell research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration ("FDA") to discuss a proposed IND to use Stemedica's proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke.

21 Aug 2009

Interfix receives AHDI Integrity Award for Innovation Through Technology

InterFix LLC is the 2009 recipient of the AHDI Integrity Award for Innovation Through Technology for the release of its BenchMark KB™ Knowledge Base product in 2008. The Integrity Awards focus on contributions made by individuals and corporations that align with the Association’s focus on integrity. The awards are designed to highlight innovative thinking and best practices that the Association believes will drive the clinical documentation sector in the coming years.

21 Aug 2009

Cannabis chemicals stop prostate cancer growth

Active chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer today.

21 Aug 2009

WFP says more than 1M Kenyans need food aid due to drought; India increases food distribution to deal with drought

More than 1 million Kenyans living in prolonged drought conditions are not getting the food aid they need, Gabrielle Menezes, a spokeswoman for the U.N.'s World Food Program (WFP), said recently, the Associated Press reports. She said WFP already provides emergency food aid to about 2.5 million people in Kenya, but another 1.3 million still need help.

21 Aug 2009

Research News and Research

Daschle advising Obama, health industry on reform

Brits defend National Health Service against U.S. criticism

Dems in conflict on health reform options, Mccain defends GOP 'end of life' claims

House Liberals: Bill must include public option

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

MarrowXpress System used for isolation and retrieval of bone marrow-derived adult stem cells

Cortex Pharmaceuticals receives delisting notification from NYSE Amex

Vendor-neutral sales performance management community launched by SPM leader Callidus Software

PTSD could be treated with Craniosacral therapy according to a research study

Ron Demuth of ChemDiv announces extension of collaboration with Lilly

Condom Olympics event to select an ambassador from Miss Universe contestants to spread messages about HIV prevention

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

HCCA's Research Compliance Conference to address Compliance Issues in International Clinical Trials

State round-up: Colorado's medicaid woes, Utah's Health Exchange, and more

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

Inc. magazine ranks Signature Genomic Laboratories no.1012 on its fastest-growing private companies ranking list

Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials

Interfix receives AHDI Integrity Award for Innovation Through Technology

Cannabis chemicals stop prostate cancer growth

WFP says more than 1M Kenyans need food aid due to drought; India increases food distribution to deal with drought

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics